Thursday July 16, 2026 1:00 AM ET

Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma

Wednesday July 15, 2026 1:00 AM ET

Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference

Monday July 6, 2026 1:00 AM ET

Molecular Partners Updates on Clinical Progress Across Expanding Pipeline of DARPin Radiotherapeutics

Thursday July 2, 2026 1:00 AM ET

Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712

Saturday May 30, 2026 8:00 AM ET

Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1

Tuesday May 12, 2026 4:00 PM ET

Molecular Partners Reports Financial Results and Highlights for Q1 2026, with Clinical Studies Initiated on MP0712 and MP0317

Monday May 4, 2026 1:00 AM ET

Molecular Partners to hold oral presentations on DLL3-targeting Radio-DARPin candidate MP0712 at multiple upcoming scientific conferences

Friday May 1, 2026 7:00 AM ET

Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling

Sunday April 19, 2026 12:00 PM ET

Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712

Tuesday April 14, 2026 4:00 PM ET

Molecular Partners Announces all Board Proposals Approved, Clare Fisher Elected as New Board Member at Annual General Meeting

Monday March 23, 2026 9:00 AM ET

Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors

Thursday March 19, 2026 2:00 AM ET

Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins’ Amenability to Multiple Isotopes

Tuesday March 17, 2026 4:30 PM ET

Molecular Partners to Hold Three Poster Presentations at AACR 2026

Thursday March 12, 2026 4:00 PM ET

Molecular Partners Reports Highlights and Financial Results for Full Year 2025

Thursday February 26, 2026 1:00 AM ET

Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results